Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 010996

Expand all

DARVON COMPOUND (ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE)
389MG;32.4MG;32MG
Marketing Status: Discontinued

Active Ingredient: ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
Proprietary Name: DARVON COMPOUND
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 389MG;32.4MG;32MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010996
Product Number: 006
Approval Date: Mar 8, 1983
Applicant Holder Full Name: XANODYNE PHARMACEUTICS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

DARVON COMPOUND-65 (ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE)
389MG;32.4MG;65MG
Marketing Status: Discontinued

Active Ingredient: ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
Proprietary Name: DARVON COMPOUND-65
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 389MG;32.4MG;65MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010996
Product Number: 007
Approval Date: Mar 8, 1983
Applicant Holder Full Name: XANODYNE PHARMACEUTICS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

DARVON W/ ASA (ASPIRIN; PROPOXYPHENE HYDROCHLORIDE)
325MG;65MG
Marketing Status: Discontinued

Active Ingredient: ASPIRIN; PROPOXYPHENE HYDROCHLORIDE
Proprietary Name: DARVON W/ ASA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 325MG;65MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010996
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: XANODYNE PHARMACEUTICS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information